Myriad RBM, Inc., a leading player in the biotechnology sector, is headquartered in the United States and operates extensively across North America and Europe. Founded in 2005, the company has established itself as a pioneer in biomarker discovery and development, focusing on advancing personalised medicine. Myriad RBM offers a unique suite of services, including multiplex immunoassays and biomarker analysis, which are integral to clinical trials and research. Their innovative approach to high-throughput protein analysis sets them apart in the industry, enabling clients to gain deeper insights into disease mechanisms and treatment efficacy. With a strong market position, Myriad RBM has achieved significant milestones, including collaborations with major pharmaceutical companies and contributions to numerous successful drug development programmes. Their commitment to scientific excellence continues to drive advancements in healthcare and personalised treatment solutions.
We don't have data for Myriad RBM, Inc., but we can show you information about their parent organization instead.
View parent company